{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T19:53:46Z","timestamp":1780084426874,"version":"3.54.0"},"reference-count":76,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2010,3,11]],"date-time":"2010-03-11T00:00:00Z","timestamp":1268265600000},"content-version":"vor","delay-in-days":10,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J American Geriatrics Society"],"published-print":{"date-parts":[[2010,3]]},"abstract":"<jats:p>\n                    The syndrome of chronic obstructive pulmonary disease (COPD) consists of chronic bronchitis (CB), bronchiectasis, emphysema, and reversible airway disease that combine uniquely in an individual patient. Older patients are at risk for COPD and its components\u2014emphysema, CB, and bronchiectasis. Bacterial and viral infections play a role in acute exacerbations of COPD (AECOPD) and in acute exacerbations of CB (AECB) without features of COPD. Older patients are at risk for resistant bacterial organisms during their episodes of AECOPD and AECB. Organisms include the more\u2010common bacteria implicated in AECOPD\/AECB such as\n                    <jats:italic>Haemophilus influenzae<\/jats:italic>\n                    ,\n                    <jats:italic>Moraxella catarrhalis<\/jats:italic>\n                    , and\n                    <jats:italic>Streptococcus pneumoniae<\/jats:italic>\n                    . Less\u2010common nonenteric, gram\u2010negative organisms including\n                    <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                    , gram\u2010positive organisms including\n                    <jats:italic>Staphylococcus aureus<\/jats:italic>\n                    , and strains of nontuberculosis Mycobacteria are more often seen in AECOPD\/AECB episodes involving elderly patients with frequent episodes of CB or those with bronchiectasis. Risk\u2010stratified antibiotic treatment guidelines appear useful for purulent episodes of AECOPD and episodes of AECB. These guidelines have not been prospectively validated for the general population and especially not for the elderly population. Using a risk\u2010stratification approach for elderly patients, first\u2010line antibiotics (e.g., amoxicillin, ampicillin, pivampicillin, trimethoprim\/sulfamethoxazole, and doxycycline), with a more\u2010limited spectrum of antibacterial coverage, are used in patients who are likely to have a low probability of resistant organisms during AECOPD\/AECB. Second\u2010line antibiotics (e.g., amoxicillin\/clavulanic acid, second\u2010 or third\u2010generation cephalosporins, and respiratory fluoroquinolones) with a broader spectrum of coverage are reserved for patients with significant risk factors for resistant organisms and those who have failed initial antibiotic treatment.\n                  <\/jats:p>","DOI":"10.1111\/j.1532-5415.2010.02741.x","type":"journal-article","created":{"date-parts":[[2010,3,11]],"date-time":"2010-03-11T14:54:29Z","timestamp":1268319269000},"page":"570-579","source":"Crossref","is-referenced-by-count":38,"title":["The Diagnosis and Treatment of Elderly Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Chronic Bronchitis"],"prefix":"10.1111","volume":"58","author":[{"given":"Timothy E.","family":"Albertson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Louie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew L.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,3,11]]},"reference":[{"key":"e_1_2_9_2_2","first-page":"S77","article-title":"ATS guidelines. Diagnosis and care of patients with COPD","volume":"152","author":"Celli BR","year":"1995","journal-title":"I. definitions epidemiology; pathophysiology; diagnosis and prognosis"},{"key":"e_1_2_9_3_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pathol.4.110807.092145"},{"key":"e_1_2_9_4_2","doi-asserted-by":"publisher","DOI":"10.1155\/2003\/486285"},{"key":"e_1_2_9_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2003.07.002"},{"key":"e_1_2_9_6_2","doi-asserted-by":"publisher","DOI":"10.1513\/pats.200508-081JS"},{"key":"e_1_2_9_7_2","first-page":"555","article-title":"Acute exacerbations of chronic bronchitis in elderly patients","volume":"24","author":"Hayes D","year":"2007","journal-title":"Pathogenesis, diagnosis and management"},{"key":"e_1_2_9_8_2","doi-asserted-by":"publisher","DOI":"10.1177\/1753465807082692"},{"key":"e_1_2_9_9_2","first-page":"397","article-title":"Chronic obstructive pulmonary disease","volume":"27","author":"Lopez AD","year":"2006","journal-title":"Current burden and future projections"},{"key":"e_1_2_9_10_2","first-page":"741","article-title":"International variation in the prevalence of COPD (the BOLD Study)","volume":"370","author":"Buist AS","year":"2007","journal-title":"A population-based prevalence study"},{"key":"e_1_2_9_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2006.11.019"},{"key":"e_1_2_9_12_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-1419"},{"key":"e_1_2_9_13_2","first-page":"99","article-title":"COPD exacerbations","volume":"98","author":"Pauwels R","year":"2004","journal-title":"The importance of a standard definition"},{"key":"e_1_2_9_14_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.117.5_suppl_2.398S"},{"key":"e_1_2_9_15_2","doi-asserted-by":"publisher","DOI":"10.1513\/pats.200701-003FM"},{"key":"e_1_2_9_16_2","first-page":"761","article-title":"Chronic obstructive pulmonary disease","volume":"19","author":"Murphy TF","year":"2002","journal-title":"Role of bacteria and guide to antibacterial selection in the older patient"},{"key":"e_1_2_9_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.qco.0000224815.89363.15"},{"key":"e_1_2_9_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2007.00305.x"},{"key":"e_1_2_9_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012561"},{"key":"e_1_2_9_20_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-2062"},{"key":"e_1_2_9_21_2","first-page":"689","article-title":"Acute exacerbation of chronic bronchitis","volume":"10","author":"Brunton S","year":"2004","journal-title":"A primary care consensus guideline"},{"key":"e_1_2_9_22_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-106-2-196"},{"key":"e_1_2_9_23_2","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/jama.1995.03520360071042","article-title":"Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta\u2010analysis","volume":"273","author":"Saint S","year":"1995","journal-title":"JAMA"},{"key":"e_1_2_9_24_2","first-page":"1684","article-title":"Interpreting COPD prevalence estimates","volume":"123","author":"Halbert RJ","year":"2003","journal-title":"What is the true burden of disease?"},{"key":"e_1_2_9_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(00)88310-1"},{"key":"e_1_2_9_26_2","first-page":"1S","article-title":"The impact of COPD on lung health worldwide","volume":"117","author":"Hurd S.","year":"2000","journal-title":"Epidemiology and incidence"},{"key":"e_1_2_9_27_2","first-page":"843","article-title":"Admissions to hospital with exacerbations of chronic obstructive pulmonary disease","volume":"61","author":"Connolly MJ","year":"2006","journal-title":"Effect of age related factors and service organisation"},{"key":"e_1_2_9_28_2","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.57.2.137"},{"key":"e_1_2_9_29_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1524-4733.2001.45049.x"},{"key":"e_1_2_9_30_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-0776"},{"key":"e_1_2_9_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0b013e328312ed8c"},{"key":"e_1_2_9_32_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200305-648OC"},{"key":"e_1_2_9_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.cpm.0000171422.98696.ed"},{"key":"e_1_2_9_34_2","first-page":"336","article-title":"Bacterial infection in chronic obstructive pulmonary disease in 2000","volume":"14","author":"Sethi S","year":"2001","journal-title":"A state-of-the-art review"},{"key":"e_1_2_9_35_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.117.5_suppl_2.380S"},{"key":"e_1_2_9_36_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.157.5.9711044"},{"key":"e_1_2_9_37_2","first-page":"1542","article-title":"Infective exacerbations of chronic bronchitis","volume":"113","author":"Eller J","year":"1998","journal-title":"Relation between bacteriologic etiology and lung function"},{"key":"e_1_2_9_38_2","doi-asserted-by":"publisher","DOI":"10.1086\/430783"},{"key":"e_1_2_9_39_2","doi-asserted-by":"publisher","DOI":"10.1086\/320181"},{"key":"e_1_2_9_40_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-200421130-00003"},{"key":"e_1_2_9_41_2","doi-asserted-by":"publisher","DOI":"10.1086\/430829"},{"key":"e_1_2_9_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(06)70599-0"},{"key":"e_1_2_9_43_2","doi-asserted-by":"publisher","DOI":"10.1097\/SMJ.0b013e3181836b73"},{"key":"e_1_2_9_44_2","unstructured":"From the Global Strategy for the Diagnosis MaPoC Global Initiative for Chronic Obstructive Lung Disease (GOLD). From the Global Strategy for the Diagnosis Management and Prevention of COPD Global Initiative for Chronic Obstructive Lung Disease (GOLD) [on\u2010line]. Available athttp:\/\/wwwgoldcopdorg 2007 Accessed November 1 2009."},{"key":"e_1_2_9_45_2","first-page":"555","article-title":"Acute exacerbations of chronic bronchitis in elderly patients","volume":"24","author":"Hayes D","year":"2007","journal-title":"Pathogenesis, diagnosis and management"},{"key":"e_1_2_9_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2005.09.004"},{"key":"e_1_2_9_47_2","first-page":"1001","article-title":"Patient stratification in the management of acute bacterial exacerbation of chronic bronchitis","volume":"25","author":"Martinez FJ","year":"2005","journal-title":"The role of levofloxacin 750\u2003mg"},{"key":"e_1_2_9_48_2","first-page":"1A","article-title":"Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease\u20142008 update\u2014highlights for primary care","volume":"15","author":"Bourbeau J","year":"2008","journal-title":"Can Respir J"},{"key":"e_1_2_9_49_2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4414\/smw.2003.10025","article-title":"Acute exacerbations of COPD","volume":"133","author":"MacNee W.","year":"2003","journal-title":"Swiss Med Wkly"},{"key":"e_1_2_9_50_2","doi-asserted-by":"crossref","unstructured":"McCroryDC BrownCD.Anti\u2010cholinergic bronchodilators versus beta2\u2010sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2002: CD003900.","DOI":"10.1002\/14651858.CD003900"},{"key":"e_1_2_9_51_2","first-page":"447","article-title":"Chronic obstructive pulmonary disease in the elderly","volume":"26","author":"Dzierba AL","year":"2009","journal-title":"An update on pharmacological management"},{"key":"e_1_2_9_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2005.08.004"},{"key":"e_1_2_9_53_2","first-page":"756","article-title":"Contemporary management of acute exacerbations of COPD","volume":"133","author":"Quon BS","year":"2008","journal-title":"A systematic review and metaanalysis"},{"key":"e_1_2_9_54_2","first-page":"2301","article-title":"Contemporary management of chronic obstructive pulmonary disease","volume":"290","author":"Sin DD","year":"2003","journal-title":"Scientific review"},{"key":"e_1_2_9_55_2","first-page":"1A","article-title":"Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease\u20142008 update\u2014highlights for primary care","volume":"15","author":"O'Donnell DE","year":"2008","journal-title":"Can Respir J"},{"key":"e_1_2_9_56_2","first-page":"415","article-title":"Short\u2010course antibiotic treatment in acute exacerbations of chronic bronchitis and COPD","volume":"63","author":"El Moussaoui R","year":"2008","journal-title":"A meta-analysis of double-blind studies"},{"key":"e_1_2_9_57_2","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S681"},{"key":"e_1_2_9_58_2","doi-asserted-by":"crossref","unstructured":"RamFS Rodriguez\u2010RoisinR Granados\u2010NavarreteAet alAntibiotics for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006: CD004403.","DOI":"10.1002\/14651858.CD004403.pub2"},{"key":"e_1_2_9_59_2","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmm023"},{"key":"e_1_2_9_60_2","first-page":"447","article-title":"Comparison of first\u2010line with second\u2010line antibiotics for acute exacerbations of chronic bronchitis","volume":"132","author":"Dimopoulos G","year":"2007","journal-title":"A metaanalysis of randomized controlled trials"},{"key":"e_1_2_9_61_2","first-page":"1127","article-title":"Macrolides, quinolones and amoxicillin\/clavulanate for chronic bronchitis","volume":"29","author":"Siempos II","year":"2007","journal-title":"A meta-analysis"},{"key":"e_1_2_9_62_2","first-page":"60","article-title":"Penicillins vs trimethoprim\u2010based regimens for acute bacterial exacerbations of chronic bronchitis","volume":"55","author":"Korbila IP","year":"2009","journal-title":"Meta-analysis of randomized controlled trials"},{"key":"e_1_2_9_63_2","first-page":"442","article-title":"Short\u2010 versus long\u2010duration antimicrobial treatment for exacerbations of chronic bronchitis","volume":"62","author":"Falagas ME","year":"2008","journal-title":"A meta-analysis"},{"key":"e_1_2_9_64_2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2147\/COPD.S1189","article-title":"Use of azithromycin in the treatment of acute exacerbations of COPD","volume":"3","author":"Milstone AP.","year":"2008","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"e_1_2_9_65_2","doi-asserted-by":"publisher","DOI":"10.1155\/2000\/417298"},{"key":"e_1_2_9_66_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.125.3.953"},{"key":"e_1_2_9_67_2","doi-asserted-by":"publisher","DOI":"10.1053\/rmed.2003.1435"},{"key":"e_1_2_9_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(01)80031-X"},{"key":"e_1_2_9_69_2","first-page":"45","article-title":"Efficacy of amoxycillin versus amoxycillin\/clavulanate in acute exacerbations of chronic pulmonary obstructive disease in primary care","volume":"4","author":"Llor C","year":"2009","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"e_1_2_9_70_2","first-page":"52","article-title":"Levofloxacin 500\u2003mg once daily versus cefuroxime 250\u2003mg twice daily in patients with acute exacerbations of chronic obstructive bronchitis","volume":"30","author":"Petitpretz P","year":"2007","journal-title":"Clinical efficacy and exacerbation-free interval"},{"key":"e_1_2_9_71_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.123.3.772"},{"key":"e_1_2_9_72_2","first-page":"1175","article-title":"Levofloxacin 750\u2003mg QD for five days versus amoxicillin\/clavulanate 875\u2003mg\/125\u2003mg BID for ten days for treatment of acute bacterial exacerbation of chronic bronchitis","volume":"28","author":"Grossman RF","year":"2006","journal-title":"A post hoc analysis of data from severely ill patients"},{"key":"e_1_2_9_73_2","first-page":"1504","article-title":"Moxifloxacin versus levofloxacin against acute exacerbations of chronic bronchitis","volume":"100","author":"Urueta\u2010Robledo J","year":"2006","journal-title":"The Latin American Cohort"},{"key":"e_1_2_9_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2003.09.012"},{"key":"e_1_2_9_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2006.08.043"},{"key":"e_1_2_9_76_2","doi-asserted-by":"publisher","DOI":"10.1179\/joc.2002.14.6.597"},{"key":"e_1_2_9_77_2","doi-asserted-by":"publisher","DOI":"10.1177\/147323000102900408"}],"container-title":["Journal of the American Geriatrics Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1532-5415.2010.02741.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1532-5415.2010.02741.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T19:22:53Z","timestamp":1762197773000},"score":1,"resource":{"primary":{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/10.1111\/j.1532-5415.2010.02741.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":76,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["10.1111\/j.1532-5415.2010.02741.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1532-5415.2010.02741.x","archive":["Portico"],"relation":{},"ISSN":["0002-8614","1532-5415"],"issn-type":[{"value":"0002-8614","type":"print"},{"value":"1532-5415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}